HealthDay News — Compared with manual screening, an artificial intelligence (AI)-assisted patient screening tool can improve the rate of eligibility determination and enrollment for randomized ...

A new study in the journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.

Implementation of patient navigation services to improve colorectal cancer health literacy in a vulnerable community health center population. Evaluating the impact of translational research ...

GPT-4 outperforms GPT-3.5 in clinical trial patient screening but is slower and more expensive, requiring human oversight due to potential errors. Low patient accrual in clinical trials is a major ...

Generative Artificial Intelligence (Gen AI) can rapidly and accurately screen patients for clinical trial eligibility, according to a new study from Mass General Brigham researchers. Such technology ...

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success ...

Low enrolment rates in clinical trials present a barrier to the development of novel cancer therapies. Currently, only 3% of patients with cancer participate, and many studies fail to achieve ...

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

NEWTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid ...